Cargando…

Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review

AIM: Management of cutaneous melanoma (CM) is continually evolving with adjuvant treatment of earlier stage disease. The aim of this review was to identify published epidemiological data for stages II–III CM. MATERIALS & METHODS: Systematic searches of Medline and Embase were conducted to identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Rachael, Walker, Sophie, Shui, Irene, Brandtmüller, Agnes, Cadwell, Kevin, Scherrer, Emilie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212505/ https://www.ncbi.nlm.nih.gov/pubmed/32399177 http://dx.doi.org/10.2217/mmt-2019-0022

Ejemplares similares

The Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden
por: Eriksson, Hanna, et al.
Publicado: (2021)

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma
por: Lorenzi, Maria, et al.
Publicado: (2019)

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients
por: Lee, J H, et al.
Publicado: (2019)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Staging of cutaneous melanoma
por: Mohr, P., et al.
Publicado: (2009)

Epidemiology of invasive cutaneous melanoma
por: MacKie, R. M., et al.
Publicado: (2009)

Lymph Node Ratio: Is It an Independent Prognostic Factor for Stage III Cutaneous Melanoma?
por: Salari, Abolfazl, et al.
Publicado: (2018)

Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma
por: Lee, R J, et al.
Publicado: (2018)

Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma
por: Hu, Di, et al.
Publicado: (2022)

An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
por: Bensimon, Arielle G., et al.
Publicado: (2020)

Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
por: RUTKOWSKI, PIOTR, et al.
Publicado: (2014)

Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre study
por: Clayton, Bethan, et al.
Publicado: (2022)

Interpretations about gender in the epidemiology of cutaneous melanoma()
por: Miola, Anna Carolina, et al.
Publicado: (2022)

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992–2011
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017)

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors
por: Mozzillo, Nicola, et al.
Publicado: (2013)

Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival
por: Casal-Mouriño, Ana, et al.
Publicado: (2021)

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients
por: Mactier, Swetlana, et al.
Publicado: (2014)

Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma
por: Brunsgaard, Elise K., et al.
Publicado: (2023)

Burden and Risk Factors of Brain Metastases in Melanoma: A Systematic Literature Review
por: Tan, Xiang-Lin, et al.
Publicado: (2022)

Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews
por: Livingstone, Ann, et al.
Publicado: (2021)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients
por: Kruijff, S., et al.
Publicado: (2009)

Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
por: Aoude, Lauren G., et al.
Publicado: (2020)

Microsatellite instability & survival in patients with stage II/III colorectal carcinoma
por: Srdjan, Markovic, et al.
Publicado: (2016)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020)

Systematic literature review and meta-analysis of clinical outcomes and prognostic factors for melanoma brain metastases
por: Tan, Xiang-Lin, et al.
Publicado: (2022)

Dermoscopic features in different dermatopathological stages of cutaneous melanomas
por: Podolec, Katarzyna, et al.
Publicado: (2019)

Descriptive epidemiology of cutaneous melanoma – A treasure for generating hypotheses
por: Stang, Andreas, et al.
Publicado: (2021)

Differences and Similarities in Epidemiology and Risk Factors for Cutaneous and Uveal Melanoma
por: Brănișteanu, Daciana Elena, et al.
Publicado: (2023)

Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature
por: Svedman, Fernanda Costa, et al.
Publicado: (2016)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Telomere length and survival in primary cutaneous melanoma patients
por: Rachakonda, Sivaramakrishna, et al.
Publicado: (2018)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

Erratum to: S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients
por: Kruijff, S., et al.
Publicado: (2010)

Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma
por: Liu-Smith, Feng, et al.
Publicado: (2020)

Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014)

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2022)

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON)
por: Namikawa, Kenjiro, et al.
Publicado: (2017)

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients
por: Kaufman, Kimberley L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a1tajk7ut5qb674sbsusjokvmk